Selected research
Market Structure
Global Genome Annotation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Genome Annotation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Genome Annotation Service include Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp and Berry Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Genome Annotation Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genome Annotation Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genome Annotation Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Genome Annotation Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Genome Annotation Service Segment by Company
Charles River
Lexogen
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Genome Annotation Service Segment by Type
RAST Tool Kit
Viral Genome ORF Reader
Genome Annotation Service Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Genome Annotation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Annotation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Annotation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Annotation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Genome Annotation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genome Annotation Service industry.
Chapter 3: Detailed analysis of Genome Annotation Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome Annotation Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- RAST Tool Kit
- Viral Genome ORF Reader
Applications
- Hospitals and Clinics
- Biopharma Companies
- Academic & Research Organizations
- Others
Companies covered
- Charles River
- Lexogen
- Eurofins Scientific
- Natera
- BGI
- Illumina
- Roche
- LabCorp
- Berry Genomics
- Brooks Life Sciences
- Macrogen
- Personalis
- Novogene
- Genotypic Technology
- Dna Link
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Genome Annotation Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 RAST Tool Kit
- 1.2.3 Viral Genome ORF Reader
- 1.3 Market Analysis by Application
- 1.3.1 Global Genome Annotation Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals and Clinics
- 1.3.3 Biopharma Companies
- 1.3.4 Academic & Research Organizations
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Genome Annotation Service Growth Trends by Region
- 1.5.1 Global Genome Annotation Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Genome Annotation Service Market Size by Region (2021-2026)
- 1.5.3 Genome Annotation Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Genome Annotation Service Market Dynamics
- 2.1 Genome Annotation Service Industry Trends
- 2.2 Genome Annotation Service Industry Drivers
- 2.3 Genome Annotation Service Industry Opportunities and Challenges
- 2.4 Genome Annotation Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Genome Annotation Service Revenue by Company (2021-2026)
- 3.2 Global Genome Annotation Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Genome Annotation Service Key Company Head office and Area Served
- 3.4 Global Genome Annotation Service Company, Product Type & Application
- 3.5 Global Genome Annotation Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Genome Annotation Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Genome Annotation Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Genome Annotation Service Tier 1, Tier 2, and Tier 3
4 Genome Annotation Service Market by Type
- 4.1 Global Genome Annotation Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Genome Annotation Service Market Size by Type (2021-2032)
- 4.3 Global Genome Annotation Service Market Size Share by Type (2021-2032)
5 Genome Annotation Service Market by Application
- 5.1 Global Genome Annotation Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Genome Annotation Service Market Size by Application (2021-2032)
- 5.3 Global Genome Annotation Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Charles River
- 6.1.1 Charles River Company Information
- 6.1.2 Charles River Business Overview
- 6.1.3 Charles River Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Charles River Genome Annotation Service Product Portfolio
- 6.1.5 Charles River Recent Developments
- 6.2 Lexogen
- 6.2.1 Lexogen Company Information
- 6.2.2 Lexogen Business Overview
- 6.2.3 Lexogen Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Lexogen Genome Annotation Service Product Portfolio
- 6.2.5 Lexogen Recent Developments
- 6.3 Eurofins Scientific
- 6.3.1 Eurofins Scientific Company Information
- 6.3.2 Eurofins Scientific Business Overview
- 6.3.3 Eurofins Scientific Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Eurofins Scientific Genome Annotation Service Product Portfolio
- 6.3.5 Eurofins Scientific Recent Developments
- 6.4 Natera
- 6.4.1 Natera Company Information
- 6.4.2 Natera Business Overview
- 6.4.3 Natera Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Natera Genome Annotation Service Product Portfolio
- 6.4.5 Natera Recent Developments
- 6.5 BGI
- 6.5.1 BGI Company Information
- 6.5.2 BGI Business Overview
- 6.5.3 BGI Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 BGI Genome Annotation Service Product Portfolio
- 6.5.5 BGI Recent Developments
- 6.6 Illumina
- 6.6.1 Illumina Company Information
- 6.6.2 Illumina Business Overview
- 6.6.3 Illumina Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Illumina Genome Annotation Service Product Portfolio
- 6.6.5 Illumina Recent Developments
- 6.7 Roche
- 6.7.1 Roche Company Information
- 6.7.2 Roche Business Overview
- 6.7.3 Roche Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Roche Genome Annotation Service Product Portfolio
- 6.7.5 Roche Recent Developments
- 6.8 LabCorp
- 6.8.1 LabCorp Company Information
- 6.8.2 LabCorp Business Overview
- 6.8.3 LabCorp Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 LabCorp Genome Annotation Service Product Portfolio
- 6.8.5 LabCorp Recent Developments
- 6.9 Berry Genomics
- 6.9.1 Berry Genomics Company Information
- 6.9.2 Berry Genomics Business Overview
- 6.9.3 Berry Genomics Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Berry Genomics Genome Annotation Service Product Portfolio
- 6.9.5 Berry Genomics Recent Developments
- 6.10 Brooks Life Sciences
- 6.10.1 Brooks Life Sciences Company Information
- 6.10.2 Brooks Life Sciences Business Overview
- 6.10.3 Brooks Life Sciences Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Brooks Life Sciences Genome Annotation Service Product Portfolio
- 6.10.5 Brooks Life Sciences Recent Developments
- 6.11 Macrogen
- 6.11.1 Macrogen Company Information
- 6.11.2 Macrogen Business Overview
- 6.11.3 Macrogen Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Macrogen Genome Annotation Service Product Portfolio
- 6.11.5 Macrogen Recent Developments
- 6.12 Personalis
- 6.12.1 Personalis Company Information
- 6.12.2 Personalis Business Overview
- 6.12.3 Personalis Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Personalis Genome Annotation Service Product Portfolio
- 6.12.5 Personalis Recent Developments
- 6.13 Novogene
- 6.13.1 Novogene Company Information
- 6.13.2 Novogene Business Overview
- 6.13.3 Novogene Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Novogene Genome Annotation Service Product Portfolio
- 6.13.5 Novogene Recent Developments
- 6.14 Genotypic Technology
- 6.14.1 Genotypic Technology Company Information
- 6.14.2 Genotypic Technology Business Overview
- 6.14.3 Genotypic Technology Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Genotypic Technology Genome Annotation Service Product Portfolio
- 6.14.5 Genotypic Technology Recent Developments
- 6.15 Dna Link
- 6.15.1 Dna Link Company Information
- 6.15.2 Dna Link Business Overview
- 6.15.3 Dna Link Genome Annotation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Dna Link Genome Annotation Service Product Portfolio
- 6.15.5 Dna Link Recent Developments
7 North America
- 7.1 North America Genome Annotation Service Market Size (2021-2032)
- 7.2 North America Genome Annotation Service Market Size by Type
- 7.2.1 North America Genome Annotation Service Market Size by Type (2021-2026)
- 7.2.2 North America Genome Annotation Service Market Size by Type (2027-2032)
- 7.2.3 North America Genome Annotation Service Market Share by Type (2021-2032)
- 7.3 North America Genome Annotation Service Market Size by Application
- 7.3.1 North America Genome Annotation Service Market Size by Application (2021-2026)
- 7.3.2 North America Genome Annotation Service Market Size by Application (2027-2032)
- 7.3.3 North America Genome Annotation Service Market Share by Application (2021-2032)
- 7.4 North America Genome Annotation Service Market Size by Country
- 7.4.1 North America Genome Annotation Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Genome Annotation Service Market Size by Country (2021-2026)
- 7.4.3 North America Genome Annotation Service Market Size by Country (2027-2032)
- 7.4.4 North America Genome Annotation Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Genome Annotation Service Market Size (2021-2032)
- 8.2 Europe Genome Annotation Service Market Size by Type
- 8.2.1 Europe Genome Annotation Service Market Size by Type (2021-2026)
- 8.2.2 Europe Genome Annotation Service Market Size by Type (2027-2032)
- 8.2.3 Europe Genome Annotation Service Market Share by Type (2021-2032)
- 8.3 Europe Genome Annotation Service Market Size by Application
- 8.3.1 Europe Genome Annotation Service Market Size by Application (2021-2026)
- 8.3.2 Europe Genome Annotation Service Market Size by Application (2027-2032)
- 8.3.3 Europe Genome Annotation Service Market Share by Application (2021-2032)
- 8.4 Europe Genome Annotation Service Market Size by Country
- 8.4.1 Europe Genome Annotation Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Genome Annotation Service Market Size by Country (2021-2026)
- 8.4.3 Europe Genome Annotation Service Market Size by Country (2027-2032)
- 8.4.4 Europe Genome Annotation Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Genome Annotation Service Market Size (2021-2032)
- 9.2 China Genome Annotation Service Market Size by Type
- 9.2.1 China Genome Annotation Service Market Size by Type (2021-2026)
- 9.2.2 China Genome Annotation Service Market Size by Type (2027-2032)
- 9.2.3 China Genome Annotation Service Market Share by Type (2021-2032)
- 9.3 China Genome Annotation Service Market Size by Application
- 9.3.1 China Genome Annotation Service Market Size by Application (2021-2026)
- 9.3.2 China Genome Annotation Service Market Size by Application (2027-2032)
- 9.3.3 China Genome Annotation Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Genome Annotation Service Market Size (2021-2032)
- 10.2 Asia Genome Annotation Service Market Size by Type
- 10.2.1 Asia Genome Annotation Service Market Size by Type (2021-2026)
- 10.2.2 Asia Genome Annotation Service Market Size by Type (2027-2032)
- 10.2.3 Asia Genome Annotation Service Market Share by Type (2021-2032)
- 10.3 Asia Genome Annotation Service Market Size by Application
- 10.3.1 Asia Genome Annotation Service Market Size by Application (2021-2026)
- 10.3.2 Asia Genome Annotation Service Market Size by Application (2027-2032)
- 10.3.3 Asia Genome Annotation Service Market Share by Application (2021-2032)
- 10.4 Asia Genome Annotation Service Market Size by Country
- 10.4.1 Asia Genome Annotation Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Genome Annotation Service Market Size by Country (2021-2026)
- 10.4.3 Asia Genome Annotation Service Market Size by Country (2027-2032)
- 10.4.4 Asia Genome Annotation Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Genome Annotation Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Genome Annotation Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Genome Annotation Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Genome Annotation Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Genome Annotation Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Genome Annotation Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Genome Annotation Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Genome Annotation Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Genome Annotation Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Genome Annotation Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Genome Annotation Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Genome Annotation Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Genome Annotation Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Genome Annotation Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst